Shao-Ta Lu
CIK: 0002125689
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YD Bio Ltd
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 30, 2026YDES
YD Bio Ltd
Exercise(M)Direct3.1K shares- - Sep 30, 2026YDES
YD Bio Ltd
Award(A)DirectRestricted Share Units
3.1K shares- - Jun 30, 2026YDES
YD Bio Ltd
Exercise(M)Direct5.7K shares- - Jun 30, 2026YDES
YD Bio Ltd
Award(A)DirectRestricted Share Units
5.7K shares- - Mar 31, 2026YDES
YD Bio Ltd
Exercise(M)Direct2.1K shares- - Mar 31, 2026YDES
YD Bio Ltd
Award(A)DirectRestricted Share Units
2.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | YDES YD Bio Ltd | Exercise(M) | 3,135 | - | $0 | Direct |
| Sep 30, 2026 | YDES YD Bio Ltd | Award(A) Restricted Share Units | 3,135 | - | - | Direct |
| Jun 30, 2026 | YDES YD Bio Ltd | Exercise(M) | 5,749 | - | $0 | Direct |
| Jun 30, 2026 | YDES YD Bio Ltd | Award(A) Restricted Share Units | 5,749 | - | - | Direct |
| Mar 31, 2026 | YDES YD Bio Ltd | Exercise(M) | 2,081 | - | $0 | Direct |
| Mar 31, 2026 | YDES YD Bio Ltd | Award(A) Restricted Share Units | 2,081 | - | - | Direct |
1-6 of 6 transactions
About Lu Shao-Ta
Lu Shao-Ta (SEC CIK 0002125689) files insider reports with the SEC as Director of YD Bio Ltd (YDES).
Signal8 holds 5 ownership filings by Lu Shao-Ta (2 Form 3, 3 Form 4), filed between Apr 2, 2026 and Oct 6, 2026. Those filings report 6 transactions, from Mar 31, 2026 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lu Shao-Ta's filings is in TAIPEI CITY.
Recent filings by Lu Shao-Ta
- Sep 30, 2026: Option exercise of YDES shares (Form 4, code M).
- Sep 30, 2026: Grant or award of YDES derivative securities (Form 4, code A).
- Jun 30, 2026: Option exercise of YDES shares (Form 4, code M).
- Jun 30, 2026: Grant or award of YDES derivative securities (Form 4, code A).
- Mar 31, 2026: Option exercise of YDES shares (Form 4, code M).
Other insiders filing for YD Bio Ltd (YDES)
- Chang Kochi, Director
- Shen Ethan PhD, CEO
- Lee Jerry Yin-Chia, Director
- Zhang Bo-Xiang, Chief Medical Officer
- Hen Man Edmund, Chief Financial Officer